FDA Import Refusal SCS-0118366-6/11/1 — Glaxosmithkline
The FDA refused shipment SCS-0118366-6/11/1 from Glaxosmithkline (United Kingdom) on May 6, 2020. The refused product falls under Drugs and Biologics — DUTASTERIDE. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 6, 2020
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 64UDY08 DUTASTERIDE
- Charges
- 75